Appreciation
Greetings on a pleasant Sunday afternoon. Highlights of the week were our kickoff planning meetings on Tuesday, Wednesday and Thursday for the CCSG Site Visit on September 12. We began to update the Lombardi Strategic Plan to align with the submitted competitive renewal, and then considered the vignettes we want to highlight in each speaker’s presentation and on the posters. We also defined our preferred slide template. All in all, it was a lot of hard work, but it was immensely gratifying, and very productive.
|
|
Veterans Exposed to Agent Orange May Be at Increased Risk of Developing Progressive Blood Cancers
An analysis of a database of veterans exposed to Agent Orange carried out by researchers at Georgetown Lombardi and the Washington DC VA Medical Center led by hematology/oncology fellow Andrew Tiu, MD, found an association for an increased risk of developing myeloproliferative neoplasms (MPNs), which are acquired stem cell disorders that can lead to overproduction of mature blood cells complicated by an increased risk of blood clots in arteries and veins. When MPNs progress, they can become deadly leukemias. Read more about this research.
|
|
Recognizing National Cancer Survivors Month
More people than ever are surviving cancer. As of January 2022, it was estimated that there were 18.1 million cancer survivors in the United States. This represents approximately 5.4% of the population. June is National Cancer Survivors Month, and yesterday, June 4, was National Cancer Survivors Day. Georgetown Lombardi recognizes the strength and resilience of cancer survivors and the dedication of the researchers at this institution and nationwide who work to improve their lives and those of their caregivers. We invite you to attend the Georgetown Lombardi Survivorship Research Initiative Seminar on Friday, June 9. See details below.
|
|
GI Oncology Research Review |
|
Join the Ruesch Center for a review of GI oncology research from the 2023 ASCO Annual Meeting on Friday, June 23, from 10:00 a.m. - 12:00 p.m. Drs. Marshall, He, Weinberg, Noel and Mukherji will highlight the most compelling abstracts in colorectal, pancreatic, liver, and upper GI cancers. Register to receive the Zoom link.
|
|
Healthy Aging Symposium Registration Now Open
The Second Annual Georgetown Center for Healthy Aging Symposium will be held Wednesday, July 12, from 10:00 a.m. to 5:00 p.m., in the Fisher Colloquium, Hariri Building, as well as online. Titled “Advancing Knowledge about Aging to Improve Health and Health Care,” the symposium includes oral papers, panels, posters and breakout sessions on topics such as new research collaborations, career development, community outreach and grant proposal development. Networking opportunities include a luncheon and a closing wine and cheese reception. Organized by the Georgetown Center for Healthy Aging. Register now.
|
|
Monday, June 5
8:30 a.m. - 5:30 p.m.
This research symposium showcases the scholarship activities in the fields of science and education ongoing in the Department of the Biochemistry and Molecular & Cellular Biology and fosters future collaborations. View more about this event. Join the symposium in the New Research Building Auditorium or via Zoom.
|
|
CDI Postdoctoral Seminar
Thursday, June 8
3:00 - 4:00 p.m.
Emre Deniz, PhD, mentored by Aykut Uren, MD, presents “Ezrin Asserts its Roles on Osteosarcoma Metastasis Through Interacting with RNAs.” Join this seminar via Zoom.
|
|
Friday, June 9
10:00 - 11:00 a.m.
Meet the Speaker Session: 11:00 - 11:30 a.m.
Presented by Sharon Plon, MD, PhD, Dan L. Duncan Comprehensive Cancer Center Professorship, Departments of Pediatrics and Molecular and Human Genetics, and assistant dean, School of Medicine, Baylor College of Medicine. Join this presentation via Zoom.
|
|
Funding and Award Opportunities |
|
Federal Grants Digest: Colleges & Universities Edition
A weekly curated digest of federal funding opportunities of interest to colleges and universities to support programming, research, infrastructure and other efforts, provided by Thorn Run Partners. View report (for May 31, 2023).
|
|
Research With Activities Related to Diversity (ReWARD)
The ReWARD program provides support for the health-related research of scientists who are making a significant contribution to Diversity, Equity, Inclusion, and Accessibility (DEIA) and who have no current NIH research project grant funding. The ReWARD program provides funding for both the scientific research and the DEIA activities of investigators. The grant will support scientific research in areas related to the programmatic interests of one or more of the participating NIH Institutes and Centers and ongoing DEIA activities focused on enhancing diversity in the biomedical research enterprise within the United States and territories. View more information and application instructions. Application due date: Monday, June 5, at 5:00 p.m.
|
|
Phi Beta Psi Grant Proposal Invitation
The goal of the Phi Beta Psi Charity Trust is to advance cancer research nationwide to improve prevention, diagnosis and treatment by providing research grants to qualified investigators addressing original questions and hypotheses to be explored in basic and clinical studies in the field of cancer. Research applications must be focused on brain, breast, colorectal, endometrial, lung, ovarian, pancreatic, gastrointestinal tract or prostate cancer. Preference is given to young investigators with documented evidence of potential for conducting novel research of either basic or clinical aspects of cancer and cancer-related problems. Applications from established investigators exploring new and innovative areas of cancer research also will be considered. Post-doctoral fellows are not eligible. View full application information. Direct questions to Marcy Colley, marcycolleypbp@gmail.com. Applications for grants must be submitted to the office of the National Second Vice President by Thursday, June 15.
|
|
Federal Rare Cancers Funding Opportunities
The Rare Cancers Research Program (RCRP), part of the Congressionally Directed Medical Research Programs, has released its fiscal year 2023 funding opportunities. The RCRP was initiated in 2020 to provide support for research of exceptional scientific merit in the area of rare cancers research. Rare cancers are defined as cancers affecting 6 or fewer persons per 100,000 per year in the United States. Applicants will be required to provide a justification statement explaining the relevance of the investigated cancer types/subtypes that fall under the RCRP’s definition of rare cancers. Pre-application (letter of intent) is required. Direct questions to help@eBRAP.org or 301-682-5507. View the funding opportunities and application instructions for:
-
Idea Development Award: Pre-application due June 26, 5:00 p.m. ET
-
Resource and Community Development Award: Pre-application due June 26, 5:00 p.m. ET
-
Concept Award, Pre-application due July 14, 5:00 p.m. ET
|
|
Federal Pancreatic Cancer Funding Opportunities
-
Idea Development Award: Pre-application due July 10, 5:00 p.m. ET
-
Translational Research Partnership Award: Pre-application due July 10, 5:00 p.m. ET
|
|
Federal Lung Cancer Funding Opportunities
The Lung Cancer Research Program (LCRP), part of the Congressionally Directed Medical Research Programs, has released its fiscal year 2023 funding opportunities. The LCRP looks to support highly innovative, high-risk early ideas as well as more advanced translation research and early stage clinical trials. In addition, it supports researcher development with a career development-focused award mechanism. Pre-application (letter of intent) is required. Direct questions to help@eBRAP.org or 301-682-5507. View the funding opportunities and application instructions for:
-
Patient-Centered Outcomes and Survivorship Award: Pre-application due July 20, 5:00 p.m. ET
|
|
Meetings in italics should be attended by all fellows.
|
|
9:00 AM | Breast Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 528212194)
11:00 AM | GU/Melanoma Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 796253566)
12:15 PM | ASCO | Podium A / Zoom
4:00 PM | GU Tumor Board (on 1st/3rd Mondays of the month) | Podium A / Zoom (dial 646-558-8656; Meeting ID: 869742463)
|
|
9:00 AM | Hematology Path Conference - Inpatient Heme fellows + Outpatient Heme + BMT fellow | Podium A / Microsoft Teams (CME code: 80737; phone: 202-796-7323)
12:15 PM | ASCO | Podium A / Zoom
4:00 PM | Liver Tumor Board | WebEx (dial 844-302-0362; Meeting number (access code): 711 507 430, password: Mse4mGSA2N5)
5:00 PM | Breast Tumor Board | Podium A / Zoom (dial 646-558-8656; Meeting ID: 93777073374; CME code: 80044)
|
|
8:00 AM | Thoracic Tumor Board – Thoracic Fellow | Podium A / Zoom (dial 646-558-8656; Meeting ID: 941 1630 5835)
12:15 PM | No Conference | Podium A / Zoom
|
|
9:00 AM | Cancer Research Data Meeting | Douglas Kung & Prerna Singh | W302 New Research Building or Zoom
9:30 AM | Head and Neck Tumor Board - Thoracic Fellow attendance encouraged as clinic allows | Microsoft Teams
12:15 PM | No Lecture | Podium A / Zoom
12:30 PM | GI Research Meeting | WebEx (dial 844-302-0362, Meeting Number (access code): 712527865, HOST PIN: 5514)
|
|
7:00 AM | CNS Tumor Board | Zoom (dial 646-558-8656; Meeting ID: 378 807 316)
12:00 PM | Oncology Grand Rounds Lecture Series | No Lecture | Zoom
12:00 PM | No Lecture | Zoom
|
|
Connect with Georgetown Lombardi on Social Media |
|
If you would like to share news or updates from your department, please get in touch with Sarah Riehl. |
|
|
|
|
|
|
